Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 24429112)

1.

Inhaled corticosteroids in severe COPD.

Bousquet J.

Lancet Respir Med. 2013 May;1(3):177-8. doi: 10.1016/S2213-2600(13)70042-0. Epub 2013 Apr 15. No abstract available.

PMID:
24429112
2.

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis.

DiSantostefano RL, Li H, Hinds D, Galkin DV, Rubin DB.

Int J Chron Obstruct Pulmon Dis. 2014 May 7;9:457-68. doi: 10.2147/COPD.S60498. eCollection 2014.

3.

Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD.

Caramori G, Chung KF, Adcock IM.

Int J Chron Obstruct Pulmon Dis. 2014 Feb 24;9:249-56. doi: 10.2147/COPD.S32604. eCollection 2014. Review.

4.

Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.

Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.

Clin Ther. 2012 Aug;34(8):1655-66.e5. doi: 10.1016/j.clinthera.2012.06.005. Epub 2012 Jul 11.

PMID:
22789766
5.

Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial.

Martinez FJ, Boscia J, Feldman G, Scott-Wilson C, Kilbride S, Fabbri L, Crim C, Calverley PM.

Respir Med. 2013 Apr;107(4):550-9. doi: 10.1016/j.rmed.2012.12.016. Epub 2013 Jan 16. Erratum in: Respir Med. 2013 Dec;107(12):2092-3.

6.

Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.

Baker WL, Baker EL, Coleman CI.

Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.

PMID:
19637942
7.

[Role of inhaled corticosteroids in the management of COPD].

Chazan R.

Pneumonol Alergol Pol. 2009;77(2):186-91. Review. Polish. No abstract available.

8.

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.

Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Vestbo J, Wachtel A, Martinez FJ, Barnhart F, Sanford L, Lettis S, Crim C, Calverley PM.

Lancet Respir Med. 2013 May;1(3):210-23. doi: 10.1016/S2213-2600(13)70040-7. Epub 2013 Apr 12. Erratum in: Lancet Respir Med. 2013 May;1(3):186.

PMID:
24429127
9.

[Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease].

Pedersen ST.

Ugeskr Laeger. 2005 Jun 6;167(23):2504-6. Review. Danish. No abstract available.

PMID:
16008004
10.

The efficacy and safety of the novel long-acting β2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial.

Hanania NA, Feldman G, Zachgo W, Shim JJ, Crim C, Sanford L, Lettis S, Barnhart F, Haumann B.

Chest. 2012 Jul;142(1):119-27. doi: 10.1378/chest.11-2231.

PMID:
22241764
11.

Anoro Ellipta: an inhaled umeclidinium/vilanterol combination for COPD.

[No authors listed]

Med Lett Drugs Ther. 2014 Apr 14;56(1440):30-1. Review. No abstract available.

PMID:
24736248
12.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Karner C, Cates CJ, Evans DJ.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Review.

PMID:
22161409
13.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Evans DJ, Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD007033.

PMID:
21975759
14.

Modulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination.

Oliver A, Bjermer L, Quinn D, Saggu P, Thomas P, Yarnall K, Lötvall J.

Allergy. 2013 Sep;68(9):1136-42. doi: 10.1111/all.12205. Epub 2013 Aug 7.

15.

Chronic obstructive pulmonary disease.

Kerstjens H, Postma D.

Clin Evid. 2002 Jun;(7):1344-57. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):1530-45.

PMID:
12243121
16.

Fluticasone-vilanterol combination approved for COPD.

Traynor K.

Am J Health Syst Pharm. 2013 Jun 15;70(12):1008. doi: 10.2146/news130042. No abstract available.

PMID:
23719869
17.

▼Relvar Ellipta for COPD.

[No authors listed]

Drug Ther Bull. 2014 Jun;52(6):66-9. doi: 10.1136/dtb.2014.6.0258. Epub 2014 Jun 5.

PMID:
24904005
18.
19.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.

Nannini LJ, Poole P, Milan SJ, Kesterton A.

Cochrane Database Syst Rev. 2013 Aug 30;8:CD006826. doi: 10.1002/14651858.CD006826.pub2. Review.

PMID:
23990350
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk